A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): Significant reduction of macrophage infiltration and fibrosis

Gut

Volumn 55, Issue 8, 2006, Pages 1165-1173

  Reding, T ^a   Bimmler, D ^a   Perren, A ^a   Sun, L K ^a   Fortunato, F ^a   Storni, F ^a   Graf, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; COLLAGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LISINOPRIL; MESSENGER RNA; MOLECULAR MARKER; PROSTAGLANDIN E2; ROFECOXIB; TRANSFORMING GROWTH FACTOR BETA;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CHEMOTAXIS; CHRONIC INFLAMMATION; CHRONIC PANCREATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DOSE RESPONSE; DRUG DETERMINATION; DRUG EFFECT; DRUG INHIBITION; DRUG WITHDRAWAL; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; MACROPHAGE; MACROPHAGE MIGRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; TISSUE INJURY;

ANIMALS; CELL MOVEMENT; CHEMOTACTIC FACTORS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYTOKINES; DINOPROSTONE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FIBROSIS; LACTONES; MACROPHAGES; MALE; MEMBRANE PROTEINS; PANCREAS; PANCREATITIS, CHRONIC; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED STRAINS; RATS, WISTAR; RNA, MESSENGER; SULFONES;

EID: 33746156525     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.077925     Document Type: Article

References (29)

1. Schlosser W, Schlosser S, Ramadani M, et al. Cyclooxygenase-2 is overexpressed in chronic pancreatitis. Pancreas 2002;25:26-30.
2. Koliopanos A, Friess H, Kleeff J, et al. Cyclooxygenase 2 expression in chronic pancreatitis: correlation with stage of the disease and diabetes mellitus. Digestion 2001;64:240-7.
3. Emmrich J, Weber I, Nausch M, et al. Immunohistochemical characterization of the pancreatic cellular infiltrate in normal pancreas, chronic pancreatitis and pancreatic carcinoma. Digestion 1998;59:192-8.
4. Cooper PH, Mayer P, Baggiolini M. Stimulation of phagocytosis in bone marrow-derived mouse macrophages by bacterial lipopolysaccharide: correlation with biochemical and functional parameters. J Immunol 1984;133:913-22.
5. Barrios-Rodiles M, Tiraloche G, Chadee K. Lipopolysaccharide modulates Cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1 beta and TNF-alpha. J Immunol 1999;163:963-9.
6. Matheson AJ, Figgitt DP. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis. Drugs 2001;61:833-65.
7. Singh G, Ramey DR, Morfeld D, et al. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med 1996;156:1530-6.
8. Zabel Langhennig A, Holler B, Engeland K, et al. Cyclooxygenase-2 transcription is stimulated and amylase secretion is inhibited in pancreatic acinar cells after induction of acute pancreatitis. Biochem Biophys Res Commun 1999;265:545-9.
9. Song AM, Bhogat L, Singh VP, et al. Inhibition of cyctooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol 2002;283:G1166-74.
10. Ethridge RT, Chung DH, Slogoff M, et al. Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 2002;123:1311-22.
11. Ohashi K, Kim JH, Hara H, et al. WBN/Kob rats. A new spontaneously occurring model of chronic pancreatitis. Int J Pancreatol 1990;6:231-47.
12. Hashimoto T, Yamoda T, Yokoi T, et al. Apoptosis of acinar cells is involved in chronic pancreatitis in WBN/Kob rats: role of glucocorticoids. Pancreas 2000;21:296-304.
13. Shimizu K, Shiratori K, Hayashi N, et al. Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis. Pancreas 2002;24:184-90.
14. Kuno A, Yamada T, Masuda K, et al. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology 2003;124:1010-19.
15. Yamada T, Kuno A, Masuda K, et al. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Tner 2003;307:17-23.
16. Bimmler D, Schiesser M, Perren A, et al. Coordinate regulation of PSP/reg and PAP isoforms as a family of secretory stress proteins in an animal model of chronic pancreatitis. J Surg Res 2004;118:122-35.
17. Nakanishi K, Uenoyama M, Tomita N, et al. Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the sendai virus (hemagglutinating virus of Japan). Am J Pathol 2002;161:1761-72.
18. Watanabe T, Higuchi K, Hamaguchi M, et al. Monocyte chemotactic protein-1 regulates leukocyte recruitment during gastric ulcer recurrence induced by tumor necrosis factor-alpha. Am J Physiol Gastrointest Liver Physiol 2004;287:G919-28.
19. Xie MJ, Motoo Y, Su SB, et al. Expression of tumor necrosis factor-alpha, interleukin-6, and interferon-gamma in spontaneous chronic pancreatitis in the WBN/Kob rat. Pancreas 2001;22:400-8.
20. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000;69:145-82.
21. Smith WL, Garovito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996;271:33157-160.
22. Foitzik T, Hotz HG, Hotz B, et al. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis. Hepatogastroenterology 2003;50:1159-62.
23. Alhan E, Kalyoncu NI, Ercin C, et al. Effects of the celecoxib on the acute necrotizing pancreatitis in rats. Inflammation 2004;28:303-9.
24. O'Briem G, Shields CJ, Winter DC, et al. Cyclooxygenase-2 plays a central role in the genesis of pancreatitis and associated lung injury. Hepatobiliary Pancreat Dis Int 2005;4:126-9.
25. Luttenberger T, Schmid-Kotsas A, Menke A, et al. Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: implications in pathogenesis of pancreas fibrosis. Lab Invest 2000;80:47-55.
26. Bachem MG, Schneider E, Gross H, et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998;115:421-32.
27. Haber PS, Keogh GW, Apte MV, et al. Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol 1999;155:1087-95.
28. Apte MV, Wilson JS. Mechanisms of pancreatic fibrosis. Dig Dis 2004;22:273-9.
29. Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005;352:1092-102.